All In Biotech

Drug Trial Radar · NCT05248646

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.

Last checked: Nov 20, 2026Latest source record: Jul 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 530 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

530

Actual

Start

Mar 15, 2022

Primary completion

May 13, 2026

Study completion Jan 19, 2027

Sponsor

Sponsor type
Industry
First posted
Feb 21, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Primary Immunoglobulin A Nephropathy

Conditions

  • Immunoglobulin A Nephropathy

Interventions

  • Sibeprenlimab 400 mgDrug

    Solution for Injection

  • PlaceboDrug

    Placebo s.c. q 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urinary protein to creatinine ratio (uPCR) in a 24-hour collectionTime frame: At 9 months

Locations

308 sites in 31 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham - Site #336

    Birmingham, Alabama

  • Mayo Clinic Arizona - Site #363

    Phoenix, Arizona

  • University of Arkansas for Medical Sciences - Site #353

    Little Rock, Arkansas

  • Amicis Research Center - Site #341

    Granada Hills, California

  • University of CA San Diego - Site #351

    La Jolla, California

  • California Institute of Renal Research - Site #371

    La Mesa, California

  • Loma Linda University Health Care Clinical Trial Center Clinic - Site #372

    Loma Linda, California

  • Academic Medical Research Institute - Site #333

    Los Angeles, California

  • Kaiser Permanente - Southern California Permanente Medical Group SCPMG - LAMC - Site #325

    Los Angeles, California

  • Stanford University - Site #370

    Palo Alto, California

  • North America Research Institute - Site #335

    San Dimas, California

  • University of California, San Francisco - Site #377

    San Francisco, California

  • Colorado Kidney Care PC - Site #330

    Denver, Colorado

  • Mayo Clinic in Florida - Site #321

    Jacksonville, Florida

  • South Florida Research Institute - Site #323

    Lauderdale Lakes, Florida

  • Columbus Research Group - Site #376

    South Miami, Florida

  • Fides Clinical Research North Atlanta Kidney Specialists - Site #373

    Atlanta, Georgia

  • Georgia Nephrology - Site #356

    Lawrenceville, Georgia

  • University of Iowa Hospitals & Clinics - Site #359

    Iowa City, Iowa

  • Kansas Nephrology Associates - Site #322

    Wichita, Kansas

  • Ochsner Medical Center - Site #334

    New Orleans, Louisiana

  • University of Maryland - Site #355

    Baltimore, Maryland

  • MGH Harvard - Site #369

    Boston, Massachusetts

  • Brigham and Women's Hospital, Division of Renal Medicine - Site #379

    Boston, Massachusetts

  • Tufts Medical Center - Site #349

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center - Site #337

    Boston, Massachusetts

  • MGH Harvard - Site #369

    Boston, Massachusetts

  • Brigham and Women's Hospital, Division of Renal Medicine - Site #379

    Boston, Massachusetts

  • Tufts Medical Center - Site #349

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center - Site #337

    Boston, Massachusetts

  • UMASS Memorial Medical Center - Site #331

    Worcester, Massachusetts

  • UMASS Memorial Medical Center - Site #331

    Worcester, Massachusetts

  • St. Clair Nephrology Research - Site #320

    Roseville, Michigan

  • University of Minnesota - Site #345

    Minneapolis, Minnesota

  • Mayo Clinic - Rochester - Site #332

    Rochester, Minnesota

  • University of Nebraska Medical Center - Site #347

    Omaha, Nebraska

  • Davita Clinical Research - Las Vegas - Site #327

    Las Vegas, Nevada

  • Northwell Health - North Shore University Hospital NSUH - Site #346

    Great Neck, New York

  • New York University Grossman School of Medicine - Site #362

    New York, New York

  • Jacobi Medical Center - Site #364

    The Bronx, New York

Showing 40 of 308 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.